Clinical trials
Completed Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 4 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Aarhus | 4 |
| CSL Behring | 3 |
| National Center for Research Resources (NCRR) | 3 |
| Baxalta now part of Shire | 2 |
| Centre Hospitalier Universitaire de Nice | 2 |
| Takeda | 2 |
| argenx | 2 |
| Aarhus University Hospital | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Biogen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 51 |
| Charcot-Marie-Tooth Disease | 4 |
| Peripheral Nervous System Diseases | 4 |
| Rare Diseases | 4 |
| Autoimmune Diseases of the Nervous System | 3 |
| Demyelinating Diseases | 3 |
| Mental Disorders | 3 |
| Neurologic Manifestations | 3 |
| Polyradiculoneuropathy | 3 |
| Autoimmune Diseases | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.